Literature DB >> 9210756

Olfactory identification deficits in schizophrenia: correlation with duration of illness.

P J Moberg1, R L Doty, B I Turetsky, S E Arnold, R N Mahr, R C Gur, W Bilker, R E Gur.   

Abstract

OBJECTIVE: The authors examined the relationship between deficits in olfactory identification and duration of illness in young and elderly patients with schizophrenia.
METHOD: Olfactory identification performance of 38 patients with schizophrenia and 40 normal subjects was compared by using the University of Pennsylvania Smell Identification Test.
RESULTS: The schizophrenic patients demonstrated olfactory deficits relative to the comparison group, and the elderly schizophrenic patients displayed a greater magnitude of olfactory deficit than the younger patients. Independent of normal aging effects and cognitive deficit, patients with schizophrenia showed a strong relationship between olfactory identification scores and duration of illness, which suggests that olfactory abilities decline progressively over the course of the disorder.
CONCLUSIONS: In contrast to other neuropsychological measures that have been reported to be stable over the course of illness, olfactory identification abilities deteriorate steadily in patients with schizophrenia, even for those with relatively recent onset.

Entities:  

Mesh:

Year:  1997        PMID: 9210756     DOI: 10.1176/ajp.154.7.1016

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  22 in total

Review 1.  Scent of a disorder: olfactory functioning in schizophrenia.

Authors:  Paul J Moberg; Bruce I Turetsky
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

2.  Olfactory impairment in monozygotic twins discordant for schizophrenia.

Authors:  Tarik Ugur; Matthias Weisbrod; Ernst Franzek; Ute Pfüller; Heinrich Sauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

3.  Olfactory screening test: experience in 102 Italian subjects.

Authors:  A Eibenstein; A B Fioretti; C Lena; N Rosati; I Ottaviano; M Fusetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

Review 4.  Olfactory dysfunction and its measurement in the clinic and workplace.

Authors:  Richard L Doty
Journal:  Int Arch Occup Environ Health       Date:  2006-01-21       Impact factor: 3.015

5.  Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.

Authors:  Paul J Moberg; Vidyulata Kamath; Dana M Marchetto; Monica E Calkins; Richard L Doty; Chang-Gyu Hahn; Karin E Borgmann-Winter; Christian G Kohler; Raquel E Gur; Bruce I Turetsky
Journal:  Schizophr Bull       Date:  2013-05-02       Impact factor: 9.306

6.  Identification of pleasant, neutral, and unpleasant odors in schizophrenia.

Authors:  Vidyulata Kamath; Bruce I Turetsky; Paul J Moberg
Journal:  Psychiatry Res       Date:  2011-01-15       Impact factor: 3.222

7.  Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.

Authors:  Mary R Lee; Heidi J Wehring; Robert P McMahon; Jared Linthicum; Nicola Cascella; Fang Liu; Alan Bellack; Robert W Buchanan; Gregory P Strauss; Carlo Contoreggi; Deanna L Kelly
Journal:  Schizophr Res       Date:  2013-02-13       Impact factor: 4.939

8.  Impaired olfactory identification in relatives of patients with familial schizophrenia.

Authors:  L C Kopala; K P Good; K Morrison; A S Bassett; M Alda; W G Honer
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

9.  An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia.

Authors:  Bruce I Turetsky; Paul J Moberg
Journal:  Am J Psychiatry       Date:  2008-12-15       Impact factor: 18.112

10.  The influence of semantic processing on odor identification ability in schizophrenia.

Authors:  Vidyulata Kamath; Bruce I Turetsky; Sarah C Seligman; Dana M Marchetto; Jeffrey B Walker; Paul J Moberg
Journal:  Arch Clin Neuropsychol       Date:  2013-03-28       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.